A phase I trial of lapatinib in combination with carboplatin in patients with platinum sensitive recurrent epithelial ovarian cancer

被引：0
|
作者：
Kimball, K. J. [1 ]
Numnum, T. M. [1 ]
Estes, J. M. [1 ]
Kirby, T. O. [1 ]
Barnes, M. N. [1 ]
Alvarez, R. D. [1 ]
机构：
[1] UAB, Birmingham, AL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
14106
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase I trial of bortezomib and carboplatin in recurrent ovarian or primary peritoneal cancer
    Aghajanian, C
    Dizon, DS
    Sabbatini, P
    Raizer, JJ
    Dupont, J
    Spriggs, DR
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) : 5943 - 5949
  • [32] A phase-I trial of pemetrexed plus carboplatin in recurrent ovarian cancer
    Sehouli, Jalid
    Camara, Oumar
    Mahner, Sven
    Bauknecht, Thomas
    Lichtenegger, Werner
    Runnebaum, Ingo
    Look, Katherine
    Jaenicke, Fritz
    Oskay-Oezcelik, Guelten
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (05) : 861 - 868
  • [33] A phase-I trial of pemetrexed plus carboplatin in recurrent ovarian cancer
    Jalid Sehouli
    Oumar Camara
    Sven Mahner
    Thomas Bauknecht
    Werner Lichtenegger
    Ingo Runnebaum
    Katherine Look
    Fritz Jaenicke
    Guelten Oskay-Oezcelik
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 861 - 868
  • [34] Phase II study of carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer
    Matulonis, U.
    Richard, P.
    Campos, S.
    Bryan, J.
    Lee, J.
    Kendal, D.
    Krasner, C.
    Berlin, S.
    Roche, M.
    Duska, L.
    Pereira, L.
    Horowitz, N.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S23 - S24
  • [35] Phase II Study of Carboplatin and Pemetrexed for the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer
    Matulonis, Ursula A.
    Horowitz, Neil S.
    Campos, Susana M.
    Lee, Hang
    Lee, Julie
    Krasner, Carolyn N.
    Berlin, Suzanne
    Roche, Maria R.
    Duska, Linda R.
    Pereira, Lauren
    Kendall, Deborah
    Penson, Richard T.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (35) : 5761 - 5766
  • [36] Phase I study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer
    Broekman, K. Esther
    Hof, Marieke A. J.
    Touw, Daan J.
    Gietema, Jourik A.
    Nijman, Hans W.
    Lefrandt, Joop D.
    Reyners, An K. L.
    Jalving, Mathilde
    INVESTIGATIONAL NEW DRUGS, 2020, 38 (05) : 1454 - 1462
  • [37] Phase I study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer
    K. Esther Broekman
    Marieke A. J. Hof
    Daan J. Touw
    Jourik A. Gietema
    Hans W. Nijman
    Joop D. Lefrandt
    An K. L. Reyners
    Mathilde Jalving
    Investigational New Drugs, 2020, 38 : 1454 - 1462
  • [38] Phase I safety study of farletuzumab, carboplatin, and pegylated liposomal doxorubicin (PLD) in patients with platinum-sensitive epithelial ovarian cancer (EOC)
    Kim, Kenneth H.
    Jelovac, Danijela
    Armstrong, Deborah Kay
    Weil, Susan
    Phillips, Martin
    Schwartz, Benjamin M.
    Estes, Jacob Michael
    Alvarez, Ronald David
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [39] A Phase I Trial of Dasatinib, an Src-Family Kinase Inhibitor, in Combination with Paclitaxel and Carboplatin in Patients with Advanced or Recurrent Ovarian Cancer
    Secord, Angeles Alvarez
    Teoh, Deanna K.
    Barry, William T.
    Yu, Miao
    Broadwater, Gloria
    Havrilesky, Laura J.
    Lee, Paula S.
    Berchuck, Andrew
    Lancaster, Johnathan
    Wenham, Robert M.
    CLINICAL CANCER RESEARCH, 2012, 18 (19) : 5489 - 5498
  • [40] Carboplatin and etoposide combination for the treatment of recurrent epithelial ovarian cancer.
    Chauvergne, J
    ChinetCharrot, P
    Stockle, E
    Thomas, L
    Toulouse, C
    BULLETIN DU CANCER, 1996, 83 (04) : 315 - 323
12345